vs
Side-by-side financial comparison of Solaris Energy Infrastructure, Inc. (SEI) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $196.2M, roughly 1.5× Solaris Energy Infrastructure, Inc.). Solaris Energy Infrastructure, Inc. runs the higher net margin — 16.3% vs 12.8%, a 3.5% gap on every dollar of revenue. On growth, Solaris Energy Infrastructure, Inc. posted the faster year-over-year revenue change (9.2% vs -6.4%). Over the past eight quarters, Solaris Energy Infrastructure, Inc.'s revenue compounded faster (63.0% CAGR vs 4.2%).
AGL Energy Ltd is an Australian listed public company involved in both the generation and retailing of electricity and gas for residential and commercial use. It is one of the "big three" retailers in the National Electricity Market. AGL is Australia's largest electricity generator, and the nation's largest carbon emitter.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SEI vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.2M | $295.9M |
| Net Profit | $32.1M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 25.8% | 18.4% |
| Net Margin | 16.3% | 12.8% |
| Revenue YoY | 9.2% | -6.4% |
| Net Profit YoY | 1013.5% | 68.3% |
| EPS (diluted) | $0.32 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $196.2M | — | ||
| Q4 25 | $179.7M | $295.9M | ||
| Q3 25 | $166.8M | — | ||
| Q2 25 | $149.3M | $317.0M | ||
| Q1 25 | $126.3M | $316.2M | ||
| Q4 24 | $96.3M | $297.0M | ||
| Q3 24 | $75.0M | $289.5M | ||
| Q2 24 | $73.9M | $306.1M |
| Q1 26 | $32.1M | — | ||
| Q4 25 | $-1.7M | $38.0M | ||
| Q3 25 | $14.6M | — | ||
| Q2 25 | $12.0M | $-17.7M | ||
| Q1 25 | $5.3M | $22.6M | ||
| Q4 24 | $6.3M | $34.9M | ||
| Q3 24 | $-968.0K | $33.6M | ||
| Q2 24 | $6.2M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
| Q1 26 | 25.8% | — | ||
| Q4 25 | 22.2% | 18.4% | ||
| Q3 25 | 22.7% | — | ||
| Q2 25 | 23.8% | -7.5% | ||
| Q1 25 | 17.5% | 12.2% | ||
| Q4 24 | 26.7% | 16.0% | ||
| Q3 24 | 7.0% | 13.8% | ||
| Q2 24 | 16.0% | 15.0% |
| Q1 26 | 16.3% | — | ||
| Q4 25 | -0.9% | 12.8% | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 8.0% | -5.6% | ||
| Q1 25 | 4.2% | 7.1% | ||
| Q4 24 | 6.5% | 11.7% | ||
| Q3 24 | -1.3% | 11.6% | ||
| Q2 24 | 8.4% | 13.3% |
| Q1 26 | $0.32 | — | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $344.5M | $172.9M |
| Total DebtLower is stronger | $395.4M | $260.0M |
| Stockholders' EquityBook value | — | $2.0B |
| Total Assets | — | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $344.5M | — | ||
| Q4 25 | $353.3M | $172.9M | ||
| Q3 25 | $106.7M | — | ||
| Q2 25 | $99.6M | $162.2M | ||
| Q1 25 | $16.7M | $140.7M | ||
| Q4 24 | $114.3M | $177.5M | ||
| Q3 24 | $18.6M | $187.5M | ||
| Q2 24 | $5.1M | $152.9M |
| Q1 26 | $395.4M | — | ||
| Q4 25 | $184.0M | $260.0M | ||
| Q3 25 | $382.8M | — | ||
| Q2 25 | $386.2M | $346.0M | ||
| Q1 25 | $316.2M | $330.0M | ||
| Q4 24 | $315.7M | $300.0M | ||
| Q3 24 | $315.3M | $300.0M | ||
| Q2 24 | — | $319.0M |
| Q1 26 | — | — | ||
| Q4 25 | $564.3M | $2.0B | ||
| Q3 25 | $546.6M | — | ||
| Q2 25 | $399.1M | $1.9B | ||
| Q1 25 | $361.3M | $2.0B | ||
| Q4 24 | $355.6M | $2.1B | ||
| Q3 24 | $221.7M | $2.1B | ||
| Q2 24 | $204.6M | $2.1B |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $2.5B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.1B | $2.7B | ||
| Q3 24 | $939.5M | $2.7B | ||
| Q2 24 | $457.8M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | 0.13× | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.97× | 0.18× | ||
| Q1 25 | 0.88× | 0.16× | ||
| Q4 24 | 0.89× | 0.14× | ||
| Q3 24 | 1.42× | 0.14× | ||
| Q2 24 | — | 0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEI
| Leasing revenue | $105.4M | 54% |
| Service revenue | $90.9M | 46% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
